EDICX
Price
$11.46
Change
-$0.08 (-0.69%)
Updated
Oct 7 closing price
Net Assets
288.08M
RIRHX
Price
$79.37
Change
-$0.09 (-0.11%)
Updated
Oct 7 closing price
Net Assets
120.2B
Interact to see
Advertisement

EDICX vs RIRHX

Header iconEDICX vs RIRHX Comparison
Open Charts EDICX vs RIRHXBanner chart's image
Eaton Vance Global Income Builder C
Price$11.46
Change-$0.08 (-0.69%)
VolumeN/A
Net Assets288.08M
American Funds Capital Income Bldr R5E
Price$79.37
Change-$0.09 (-0.11%)
VolumeN/A
Net Assets120.2B
EDICX vs RIRHX Comparison Chart in %
View a ticker or compare two or three
VS
EDICX vs. RIRHX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDICX is a Buy and RIRHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RIRHX has more cash in the bank: 120B vs. EDICX (288M). EDICX pays higher dividends than RIRHX: EDICX (4.05) vs RIRHX (3.08). EDICX was incepted earlier than RIRHX: EDICX (20 years) vs RIRHX (10 years). EDICX (1.93) is less costly to investors than RIRHX (0.42). EDICX is a more actively managed with annual turnover of: 108.00 vs. RIRHX (56.00). RIRHX has a lower initial minimum investment than EDICX: RIRHX (250) vs EDICX (1000). RIRHX annual gain was more profitable for investors over the last year : 12.54 vs. EDICX (9.86). RIRHX return over 5 years is better than : 53.53 vs. EDICX (41.51).
EDICXRIRHXEDICX / RIRHX
Total Expense Ratio1.920.42457%
Annual Report Gross Expense Ratio1.930.42460%
Fund Existence20 years10 years-
Gain YTD15.57117.62288%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets288M120B0%
Annual Yield % from dividends4.053.08132%
Returns for 1 year9.8612.5479%
Returns for 3 years50.3750.56100%
Returns for 5 years41.5153.5378%
Returns for 10 years69.22N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SER5.400.21
+4.05%
Serina Therapeutics
EURKU10.89N/A
N/A
Eureka Acquisition Corp.
HLLY2.95-0.03
-1.01%
Holley
NVCR14.16-0.34
-2.34%
NovoCure Limited
BIO296.52-12.65
-4.09%
Bio-Rad Laboratories IncClass A